Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -4.81 Million USD | 43.98% |
| 2022 | -8.59 Million USD | 29.16% |
| 2021 | -12.13 Million USD | 73.41% |
| 2020 | -45.61 Million USD | -310.37% |
| 2019 | 21.68 Million USD | 407.4% |
| 2018 | -7.05 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | -3.66 Million USD | 57.33% |
| 2023 FY | -4.81 Million USD | 43.98% |
| 2023 Q2 | -2.64 Million USD | 27.84% |
| 2023 Q3 | -4.25 Million USD | -60.92% |
| 2023 Q4 | -4.81 Million USD | -13.06% |
| 2022 FY | -8.59 Million USD | 29.16% |
| 2022 Q4 | -8.59 Million USD | 30.04% |
| 2022 Q3 | -12.28 Million USD | 9.18% |
| 2022 Q2 | -13.52 Million USD | 24.32% |
| 2022 Q1 | -17.87 Million USD | -47.32% |
| 2021 Q2 | -22.94 Million USD | 31.58% |
| 2021 Q1 | -33.53 Million USD | 26.49% |
| 2021 FY | -12.13 Million USD | 73.41% |
| 2021 Q4 | -12.13 Million USD | 38.28% |
| 2021 Q3 | -19.65 Million USD | 14.33% |
| 2020 Q4 | -45.61 Million USD | -237.29% |
| 2020 FY | -45.61 Million USD | -310.37% |
| 2020 Q3 | 33.22 Million USD | -2.19% |
| 2020 Q2 | 33.97 Million USD | -28.98% |
| 2020 Q1 | 47.83 Million USD | 120.6% |
| 2019 Q4 | 21.68 Million USD | 0.0% |
| 2019 Q1 | 21.26 Million USD | 0.0% |
| 2019 FY | 21.68 Million USD | 407.4% |
| 2018 FY | -7.05 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 105.11% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 106.423% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 101.106% |
| Cosmos Health Inc. | 8.59 Million USD | 156.037% |
| Dynavax Technologies Corporation | 106.63 Million USD | 104.514% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 96.32% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 101.112% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 69.209% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 69.209% |
| SCYNEXIS, Inc. | -19.35 Million USD | 75.121% |
| Safety Shot Inc | -2.28 Million USD | -110.736% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 48.949% |
| Alpha Teknova, Inc. | 1.97 Million USD | 343.87% |
| Bright Green Corporation | 1.84 Million USD | 361.386% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 101.049% |
| Embecta Corp. | 1.31 Billion USD | 100.367% |
| PainReform Ltd. | -7.95 Million USD | 39.447% |
| Journey Medical Corporation | -9.7 Million USD | 50.417% |
| Procaps Group, S.A. | 242.93 Million USD | 101.982% |
| Theratechnologies Inc. | 24.87 Million USD | 119.356% |
| Harrow Health, Inc. | 116.41 Million USD | 104.135% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | -91.032% |
| Biofrontera Inc. | 4.05 Million USD | 218.688% |
| DURECT Corporation | -7.65 Million USD | 37.105% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 85.641% |
| Cronos Group Inc. | -663.32 Million USD | 99.274% |
| OptiNose, Inc. | 58.06 Million USD | 108.291% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 100.772% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 66.964% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 7.174% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 132.066% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 24.304% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | 4605.002% |
| Radius Health, Inc. | 359.28 Million USD | 101.34% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | 2541.065% |
| ProPhase Labs, Inc. | 19.23 Million USD | 125.032% |
| Phibro Animal Health Corporation | 454.84 Million USD | 101.058% |
| Procaps Group S.A. | 242.93 Million USD | 101.982% |
| Alvotech | 1.06 Billion USD | 100.452% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 230.886% |
| Viatris Inc. | 17.13 Billion USD | 100.028% |
| Rockwell Medical, Inc. | 4.45 Million USD | 208.034% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 1.292% |
| SIGA Technologies, Inc. | -148.68 Million USD | 96.762% |
| Tilray Brands, Inc. | 158.97 Million USD | 103.028% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 103.949% |
| Shineco, Inc. | 29.29 Million USD | 116.435% |
| PetIQ, Inc. | 351.93 Million USD | 101.368% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | -65.918% |
| Incannex Healthcare Limited | -5.48 Million USD | 12.233% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 102.715% |
| Alimera Sciences, Inc. | 55.3 Million USD | 108.704% |
| Silver Spike Investment Corp. | -32.61 Million USD | 85.238% |
| Assertio Holdings, Inc. | -32.52 Million USD | 85.201% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | -223.365% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 4.869% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 41.389% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 214.157% |
| Hempacco Co., Inc. | 13.61 Million USD | 135.359% |
| Talphera, Inc. | -5.72 Million USD | 15.854% |
| Alvotech | 1.06 Billion USD | 100.452% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 167.376% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 95.022% |
| Currenc Group, Inc. | -16.57 Million USD | 70.953% |
| Kamada Ltd. | -46.43 Million USD | 89.632% |
| Indivior PLC | -33.95 Million USD | 85.821% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | 1947.46% |
| Flora Growth Corp. | -713 Thousand USD | -575.175% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 41.389% |
| Evolus, Inc. | 63.7 Million USD | 107.556% |
| HUTCHMED (China) Limited | -197.45 Million USD | 97.562% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 101.005% |
| Akanda Corp. | 3.9 Million USD | 223.281% |